C3.ai Inc (NYSE: AI) Has Another Chance To Impress You

Currently, there are 120.21M common shares owned by the public and among those 109.88M shares have been available to trade.

The company’s stock has a 5-day price change of 42.65% and 60.90% over the past three months. AI shares are trading 31.87% year to date (YTD), with the 12-month market performance up to 31.05% higher. It has a 12-month low price of $18.85 and touched a high of $38.30 over the same period. AI has an average intraday trading volume of 4.57 million shares. The stock is trading above its simple moving averages at the SMA20, SMA50, and SMA200, as the current price level is off by 31.94%, 43.95%, and 42.85% respectively.

3 Tiny Stocks Primed to Explode The world's greatest investor — Warren Buffett — has a simple formula for making big money in the markets. He buys up valuable assets when they are very cheap. For stock market investors that means buying up cheap small cap stocks like these with huge upside potential.

We've set up an alert service to help smart investors take full advantage of the small cap stocks primed for big returns.

Click here for full details and to join for free
Sponsored

Institutional ownership of C3.ai Inc (NYSE: AI) shares accounts for 46.11% of the company’s 120.21M shares outstanding.

It has a market capitalization of $5.14B and a beta (3y monthly) value of 1.95. The earnings-per-share (ttm) stands at -$2.29. Price movements for the stock have been influenced by the stock’s volatility, which stands at 11.42% over the week and 6.09% over the month.

Earnings per share for the fiscal year are expected to decrease by -14.73%, and 37.23% over the next financial year.

Looking at the support for the AI, a number of firms have released research notes about the stock. Northland Capital stated their Outperform rating for the stock in a research note on May 30, 2024, with the firm’s price target at $35. Oppenheimer coverage for the C3.ai Inc (AI) stock in a research note released on November 21, 2023 offered a Outperform rating with a price target of $40. Wedbush on their part issued Outperform rating on June 01, 2023.

Most Popular

Related Posts